Coronavirus vaccine with 50% or more efficacy would be a 'game changer,' says trial investigatorCNBC • 08/18/20
Wall Street's top analysts see stocks like Dropbox and Lumentum as compelling opportunitiesCNBC • 08/16/20
Moderna and Other Coronavirus Vaccine Makers to Take Reduced Payments If Approval Milestones Not MetThe Motley Fool • 08/15/20
The U.S. has already invested billions on potential coronavirus vaccines. Here's where the deals standCNBC • 08/14/20
Moderna Analysts Say COVID-19 Vaccine Contract Reflects Pricing Risk, Shows Ability To ScaleBenzinga • 08/12/20
Moderna Stock Surges on $1.5 Billion Coronavirus Vaccine Deal with the U.S. GovernmentThe Motley Fool • 08/12/20
Moderna Inks $1.5 Billion Coronavirus Vaccine Supply Deal With U.S.; Stock PopsInvestors Business Daily • 08/12/20
Moderna Strikes $1.5B Supply Agreement With US For 100M Doses Of Coronavirus VaccineBenzinga • 08/11/20
Why Sorrento Therapeutics, Novavax, Moderna, and Other Coronavirus Stocks Plunged TodayThe Motley Fool • 08/11/20
Moderna stock pops after agreement to sell at least 100 million COVID-19 vaccine doses to U.S. governmentMarket Watch • 08/11/20
Trump says U.S. has reached deal with Moderna for 100 million doses of coronavirus vaccineCNBC • 08/11/20